Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02804399 · ClinicalTrials.gov registry record · Phase 1
A Study To Evaluate The Effect Of Rifampin On Pharmacokinetics Of PF-06463922 In Healthy Volunteers
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT02804399 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 12 participants.
The verdict
NCT02804399, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to estimate the effect of rifampin on the single dose PK of PF-06463922.
Interventions
- DRUG rifampin
- DRUG PF-06463922
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-07 |
| Est. Completion | 2016-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02804399
The ClinicalTrials.gov registry entry for NCT02804399 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which rifampin is the first listed.
NCT02804399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02804399 about?
NCT02804399 is a clinical study titled "A Study To Evaluate The Effect Of Rifampin On Pharmacokinetics Of PF-06463922 In Healthy Volunteers". The purpose of this study is to estimate the effect of rifampin on the single dose PK of PF-06463922.
What is the current status of trial NCT02804399?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2016-07. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02804399?
The interventions under investigation include: rifampin (DRUG), PF-06463922 (DRUG).
Who is sponsoring clinical trial NCT02804399?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.